ARCHIVES

FDA, NCI, Congress Shape Pediatric Drug Development Proposals

This article is from The Cancer Letter archive.

Vol. 29 No. 15 | April 11, 2003

Download PDF Visit The Full Archive

Related Articles

Genentech Move Nixes Hospital Discounts: Avastin, Herceptin, Rituxan Now Sold Under Tighter Control by Drug Maker

October 3, 2014

Obituary: Sydney Salmon, 63, Founding Director, Arizona Cancer Center

October 15, 1999

Mammography Had Limited Impact Among Swedish Women Age 40-69

July 27, 2012

In Brief: Cancer Act Renewal Hearings Completed ; Administration Stays With Objections To More Centers, Specific Budget Figures

February 22, 1974

NIH Chemical Genomics Center to screen small molecules.

June 18, 2004

NCI Resumes Clinical Education Grants

March 18, 1983